JSNM2024/JSNMT2024

Session information

Print

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 20:Pharmaceutical Synthesis・Quality Control 2

Thu. Nov 7, 2024 3:20 PM - 4:00 PM Room 7 (3F 304, Conference Center, PACIFICO Yokohama)

座長：古本 祥三（東北大学 先端量子ビーム科学研究センター）、淵上 剛志（金沢大学 医薬保健研究域）

[1-MO20-1] Volatility of dissolved astatine

Ichiro Nishinaka1、Kazuyuki Hashimoto2 (1.Department of Quantum-Applied Biosciences, Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology, Takasaki, Japan、2.Department of Research Reactor and Tandem Accelerator, Nuclear Science Research Institute, Japan Atomic Energy Agency, Tokai, Japan)

[1-MO20-2] Process validation of [211At]PSMA-5 solution for investigator-initiated clinical trial

Sadahiro Naka1,2、Yoshifumi Shirakami3、Kazuhiro Ooe3、Kenta Kurimoto1,2、Toshihiro Sakai1、Yukiyoshi Kon3、Xiaojie Yin4、Hiromitsu Haba4、Atsushi Toyoshima3、Tadashi Watabe1,3、Noriyuki Tomiyama1,3 (1.Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan、2.Department of Pharmacy, Osaka University Hospital, Osaka, Japan、3.Institute for Radiation Sciences, Osaka University, Osaka, Japan、4.Nishina Center for Accelerator-Based Science, RIKEN, Wako, Saitama)

[1-MO20-3] Manufacture of [18F]PSMA-1007 Solution for Clinical Research

Kenta Kurimoto1,2、Sadahiro Naka1,2、Masaharu Wakahara3、Daisuke Kinoshita3、Yuta Yasuda3、Jens Cardinale5、Frederik Giesel5、Tadashi Watabe1,4 (1.Department of Radiology, Graduate School of Medicine, Osaka University, Osaka, Japan、2.Department of Pharmacy, Osaka University Hospital, Osaka, Japan、3.SHI Accelerator Sarvice、4.Institute for Radiation Sciences, Osaka University, Osaka, Japan、5.Department of Nuclear Medicine, University Hospital Duesseldorf, Medical Faculty, Heinrich-Heine-University, Germany)